scispace - formally typeset
G

Gary M. Jones

Researcher at National Institutes of Health

Publications -  44
Citations -  1733

Gary M. Jones is an academic researcher from National Institutes of Health. The author has contributed to research in topics: DNA repair & Chromatid. The author has an hindex of 22, co-authored 44 publications receiving 1718 citations.

Papers
More filters
Journal ArticleDOI

Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair

TL;DR: In this article, the authors compared 10 lines of skin fibroblasts from individuals with genetic disorders predisposing to a high risk of cancer with nine lines from normal adult donors with respect to chromatid damage after x-irradiation.
Journal ArticleDOI

Factors affecting and significance of G2 chromatin radiosensitivity in predisposition to cancer.

TL;DR: This response in skin fibroblasts from individuals with genetic conditions predisposing to cancer than in comparable cells from clinically normal controls could provide the basis of a test for detecting individuals carrying genes that predispose to a high risk of cancer.
Journal ArticleDOI

Enhanced Chromatid Damage in Blood Lymphocytes After G2 Phase X Irradiation, a Marker of the Ataxia-Telangiectasia Gene

TL;DR: The persistence of chromatid breaks and gaps in lymphocytes following radiation-induced DNA damage during G2 suggests a deficiency or deficiencies in DNA repair that may be the defect at the molecular level that results in the enhanced radiosensitivity and cancer proneness characterizing A-T gene carriers and patients.
Journal ArticleDOI

Fluorescent light-induced chromosome damage and its prevention in mouse cells in culture.

TL;DR: Most of the chromosomal abnormalities observed in long-term culture of mouse cells may result from exposure of cells or medium to fluorescent room lights in the presence of atmospheric oxygen, and can be minimized by shielding cells and medium from light, lowering the PO2 of the medium, and including reducing agents such as glutathione and ascorbic acid in the medium formulation.